| BRIEF COMMUNICATION |
|
| Year : 2014 | Volume
: 57
| Issue : 2 | Page : 275-277 |
|
|
Multidrug-resistant Staphylococcus hominis subsp. novobiosepticus causing septicemia in patients with malignancy
Priyamvada Roy1, Nishat Hussain Ahmed1, Indu Biswal1, Rajesh Kumar Grover2
1 Department of Laboratory Medicine, Delhi State Cancer Institute, Dilshad Garden, New Delhi, India
2 Department of Clinical Oncology, Delhi State Cancer Institute, Dilshad Garden, New Delhi, India
Correspondence Address:
Nishat Hussain Ahmed
Laboratory Medicine, Delhi State Cancer Institute, Dilshad Garden, New Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0377-4929.134708
|
|
|
A new subspecies of Staphylococcus hominis described by Kloos et al. in 1998 and named S. hominis subsp. novobiosepticus (SHN) has been implicated in nosocomial outbreaks. Multidrug resistance, including resistance to novobiocin and oxacillin, is a particularly important feature of SHN. In our institute, we encountered 13 cases of S. hominis subsp. hominis in cancer patients with septicemia, of which seven were methicillin resistant. The isolates were identified by VITEK ® 2 compact automated system, using GP REF 21342 identification card and antimicrobial susceptibility testing card P-628. The biochemical reactions and antibiotic susceptibility pattern of the seven methicillin-resistant isolates were re-analyzed and patient details were re-checked to finally identify them as SHN. The increasing number of cases reporting isolation of SHN from biological specimens point to potential virulence and clinical importance of this bacterium. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
